We're currently experiencing extremely high call volumes. We're very sorry for any inconvenience this might cause. If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Biostage Inc COM USD0.01(POST REV SPLIT)

Sell:$3.90 Buy:$3.90 Change: $0.45 (13.04%)
Market closed |  Prices as at close on 7 April 2020 | Switch to live prices |
Sell:$3.90
Buy:$3.90
Change: $0.45 (13.04%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 7 April 2020 | Switch to live prices |
Sell:$3.90
Buy:$3.90
Change: $0.45 (13.04%)
Market closed |  Prices as at close on 7 April 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe technology. Its Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient's own cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, trachea or bronchus that are caused due to cancer, infection, trauma or congenital abnormalities. Its Cellframe technology is engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. Its Cellframe technology platform is used to create organ specific Cellspan implants. Its product candidates are in development and have not yet received regulatory approval for sale anywhere in the world.

Contact details

Address:
84 October Hill Rd Ste 11
HOLLISTON
01746-1371
United States
Telephone:
+1 (774) 2337300
Website:
www.biostage.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
n/a
ISIN:
US09074M2026
Market cap:
$32.27 million
Shares in issue:
8.28 million
Sector:
Biotechnology
Exchange:
OTC Bulletin Board
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Jason Jing Chen
    Chairman of the Board
  • Hong Yu
    President
  • Peter Chakoutis
    Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
  • Harout DerSimonian
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.